Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

James Miller

Concepts (325)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
44
2020
2568
2.500
Why?
Smoking
20
2019
1579
1.190
Why?
Bronchi
13
2018
263
1.150
Why?
Carcinoma in Situ
5
2019
44
1.050
Why?
Carcinoma, Squamous Cell
10
2018
643
0.730
Why?
Carcinogens
4
2012
125
0.720
Why?
Chemoprevention
3
2019
95
0.690
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2012
83
0.690
Why?
Lung
16
2020
4078
0.570
Why?
Carcinoma, Small Cell
7
2008
171
0.470
Why?
Bronchoscopy
9
2019
227
0.470
Why?
Urethane
3
2012
43
0.460
Why?
Bronchopulmonary Dysplasia
2
2019
406
0.440
Why?
Sputum
8
2019
311
0.440
Why?
Pulmonary Alveoli
4
2012
392
0.440
Why?
Iloprost
2
2012
44
0.440
Why?
Hyperplasia
7
2011
174
0.430
Why?
Precancerous Conditions
7
2020
165
0.420
Why?
Neprilysin
3
1998
45
0.400
Why?
Quinazolines
2
2012
260
0.370
Why?
Biopsy
11
2019
1081
0.370
Why?
Piperidines
2
2012
220
0.370
Why?
Biomarkers, Tumor
7
2015
1262
0.370
Why?
Antineoplastic Agents
4
2013
2167
0.360
Why?
DNA Copy Number Variations
1
2011
182
0.330
Why?
Bombesin
5
1998
11
0.330
Why?
Genetic Markers
1
2011
343
0.330
Why?
Amidohydrolases
3
1998
32
0.320
Why?
Neurosecretory Systems
4
2004
31
0.310
Why?
Isotretinoin
1
2009
24
0.300
Why?
Ki-67 Antigen
3
2015
111
0.300
Why?
Tocopherols
1
2009
26
0.300
Why?
Vasodilator Agents
1
2011
330
0.300
Why?
Carcinoma, Non-Small-Cell Lung
7
2013
1128
0.300
Why?
ErbB Receptors
1
2012
615
0.290
Why?
Neovascularization, Pathologic
6
2015
295
0.270
Why?
Membrane Proteins
2
2008
1160
0.270
Why?
Mass Screening
3
2008
1325
0.270
Why?
Pulmonary Disease, Chronic Obstructive
4
2018
1045
0.270
Why?
Respiratory Mucosa
2
2008
324
0.250
Why?
Adenocarcinoma
6
2012
904
0.230
Why?
Hypoxia
1
2012
1166
0.220
Why?
Chromosomes, Human, Pair 3
4
2000
46
0.210
Why?
Carcinoma, Bronchogenic
2
2002
20
0.200
Why?
Chromosome Aberrations
4
2013
161
0.200
Why?
Tomography, Spiral Computed
1
2002
32
0.190
Why?
Middle Aged
28
2019
35049
0.190
Why?
Aged
25
2019
25117
0.190
Why?
Humans
53
2020
142526
0.180
Why?
Sensitivity and Specificity
10
2010
1977
0.170
Why?
Smokers
2
2019
146
0.170
Why?
Placebos
2
2019
195
0.170
Why?
Female
33
2019
76624
0.170
Why?
Lung Diseases
5
2015
786
0.170
Why?
Double-Blind Method
2
2019
2007
0.170
Why?
Small Cell Lung Carcinoma
2
2012
114
0.160
Why?
Tomography, X-Ray Computed
2
2020
2771
0.160
Why?
Neuropeptides
4
1998
77
0.150
Why?
Tumor Cells, Cultured
6
1998
960
0.150
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2020
119
0.150
Why?
Male
30
2019
70910
0.150
Why?
Remission Induction
1
2019
306
0.140
Why?
In Situ Hybridization, Fluorescence
6
2010
310
0.140
Why?
Peptides
3
1996
974
0.140
Why?
Blotting, Western
4
2012
1220
0.140
Why?
Genes, p53
1
1997
68
0.130
Why?
Lung Diseases, Obstructive
1
1997
43
0.130
Why?
Immunohistochemistry
8
2015
1727
0.130
Why?
Point Mutation
1
1997
240
0.130
Why?
Antibodies, Monoclonal
3
2010
1471
0.120
Why?
Radiation Injuries, Experimental
1
1996
21
0.120
Why?
Proteomics
2
2015
1152
0.120
Why?
Bradykinin
1
1996
48
0.120
Why?
Endopeptidases
1
1996
81
0.120
Why?
Chromosomal Instability
2
2013
21
0.120
Why?
Smoking Cessation
1
2019
434
0.110
Why?
Hyperoxia
1
1996
92
0.110
Why?
Multiple Pulmonary Nodules
1
2015
21
0.110
Why?
Mice
10
2012
18172
0.110
Why?
Animals
13
2013
37697
0.110
Why?
Gene Expression
3
1998
1496
0.110
Why?
Methylcholanthrene
2
2012
21
0.110
Why?
Butylated Hydroxytoluene
2
2012
36
0.100
Why?
Antigens
1
1996
349
0.100
Why?
Mice, Transgenic
5
2009
2180
0.100
Why?
Risk Factors
5
2019
10593
0.100
Why?
Microarray Analysis
1
2013
117
0.100
Why?
Stem Cells
1
2018
612
0.100
Why?
Mutation
4
2000
4024
0.100
Why?
Algorithms
3
2020
1791
0.100
Why?
Epithelium
4
2018
313
0.100
Why?
Intramolecular Oxidoreductases
2
2004
66
0.100
Why?
Aged, 80 and over
8
2015
8020
0.100
Why?
Risk
5
2012
905
0.100
Why?
Carcinoma, Large Cell
1
2012
15
0.100
Why?
Biological Products
1
1996
243
0.090
Why?
Epithelial Cells
3
2007
1116
0.090
Why?
Cytochrome P-450 Enzyme System
2
2004
159
0.090
Why?
Receptors, Bombesin
1
2012
2
0.090
Why?
Bronchoalveolar Lavage Fluid
3
2002
636
0.090
Why?
Immunoenzyme Techniques
1
2012
206
0.090
Why?
Cell Division
4
2000
794
0.090
Why?
Volatile Organic Compounds
1
2012
63
0.090
Why?
Case-Control Studies
8
2012
3604
0.090
Why?
Sleep Apnea Syndromes
1
2012
90
0.090
Why?
Dose-Response Relationship, Drug
2
2010
2053
0.090
Why?
Chromosomes, Human, Pair 15
1
2011
53
0.080
Why?
Eosinophilic Granuloma
1
1990
3
0.080
Why?
Proto-Oncogene Proteins c-myc
1
2012
164
0.080
Why?
Veterans
1
2002
1531
0.080
Why?
Epithelial-Mesenchymal Transition
1
2012
214
0.080
Why?
Antioxidants
2
2012
594
0.080
Why?
Plants, Toxic
1
1989
19
0.080
Why?
Cell Line
5
2013
2878
0.080
Why?
Proteins
1
1996
1013
0.080
Why?
Calcium
1
1996
1179
0.080
Why?
Somatomedins
1
2009
28
0.080
Why?
Genome-Wide Association Study
2
2013
1426
0.080
Why?
Predictive Value of Tests
4
2009
2081
0.080
Why?
Disease Progression
5
2018
2831
0.070
Why?
Cell Proliferation
2
2018
2514
0.070
Why?
Bronchial Neoplasms
1
2009
15
0.070
Why?
Intracellular Signaling Peptides and Proteins
2
2011
469
0.070
Why?
Chromosome Deletion
1
1989
118
0.070
Why?
Neoplasms, Glandular and Epithelial
1
2009
50
0.070
Why?
Adult
16
2018
39715
0.070
Why?
Respiratory System
1
1989
156
0.070
Why?
GPI-Linked Proteins
1
2008
78
0.070
Why?
Airway Obstruction
3
2009
166
0.070
Why?
Neoplasm Invasiveness
4
2015
512
0.070
Why?
Polymorphism, Genetic
1
2011
622
0.070
Why?
Fluorescence
3
2009
161
0.070
Why?
Alkaline Phosphatase
1
2008
146
0.070
Why?
Spectral Karyotyping
1
2007
5
0.070
Why?
Isoenzymes
1
2008
296
0.070
Why?
Molecular Targeted Therapy
1
2010
421
0.070
Why?
Cell Transformation, Neoplastic
1
2009
337
0.070
Why?
Proto-Oncogene Proteins p21(ras)
1
2008
251
0.060
Why?
Molecular Sequence Data
5
1998
2916
0.060
Why?
Pulmonary Surfactants
2
1999
103
0.060
Why?
Inflammation
1
2018
2867
0.060
Why?
Exons
2
1998
352
0.060
Why?
Fibroblasts
3
1998
1033
0.060
Why?
MicroRNAs
1
2012
696
0.060
Why?
Polymorphism, Single Nucleotide
1
2013
2146
0.060
Why?
Follow-Up Studies
2
2015
5270
0.060
Why?
Early Detection of Cancer
1
2010
441
0.060
Why?
Enzyme-Linked Immunosorbent Assay
3
2005
853
0.060
Why?
ROC Curve
3
2015
600
0.060
Why?
Recombinant Proteins
3
1998
1364
0.060
Why?
Adaptor Proteins, Signal Transducing
1
2008
440
0.060
Why?
Biomarkers
3
2010
4207
0.060
Why?
RNA, Messenger
3
1998
2828
0.050
Why?
Polymerase Chain Reaction
3
1998
1051
0.050
Why?
Growth Hormone-Releasing Hormone
1
2004
25
0.050
Why?
Acromegaly
1
2004
16
0.050
Why?
Cytokines
1
2012
2093
0.050
Why?
Protein Kinase Inhibitors
1
2010
927
0.050
Why?
Adrenocorticotropic Hormone
1
2004
147
0.050
Why?
Rats
4
2004
5585
0.050
Why?
Smoke
1
2004
149
0.050
Why?
Base Sequence
3
1998
2176
0.050
Why?
Solitary Pulmonary Nodule
1
2002
21
0.050
Why?
Neoplasm Recurrence, Local
1
2009
1087
0.050
Why?
Metaplasia
2
2018
58
0.050
Why?
Vascular Endothelial Growth Factor A
1
2005
547
0.050
Why?
Cross-Sectional Studies
2
2018
5700
0.050
Why?
Sex Factors
1
2007
2074
0.040
Why?
Hospitals, Veterans
1
2002
255
0.040
Why?
Pulmonary Fibrosis
2
1998
391
0.040
Why?
Radiation Dosage
1
2002
192
0.040
Why?
Reproducibility of Results
1
2008
3362
0.040
Why?
Gene Expression Regulation
1
1989
2608
0.040
Why?
Amino Acid Sequence
3
1994
2150
0.040
Why?
Cohort Studies
4
2015
5858
0.040
Why?
Gastrin-Releasing Peptide
2
1996
7
0.040
Why?
Autocrine Communication
1
1998
40
0.040
Why?
Desmoglein 3
1
2018
14
0.040
Why?
gamma Catenin
1
2018
13
0.040
Why?
Loss of Heterozygosity
2
2013
51
0.040
Why?
Light
1
2001
399
0.040
Why?
DNA Primers
2
1998
507
0.040
Why?
Signal Transduction
3
1998
5163
0.040
Why?
Up-Regulation
2
2005
857
0.040
Why?
Bronchial Diseases
1
2018
37
0.040
Why?
Paracrine Communication
1
1998
67
0.040
Why?
Neoplasm Transplantation
1
1998
251
0.030
Why?
Feasibility Studies
1
2002
1047
0.030
Why?
Vascular Cell Adhesion Molecule-1
1
1998
41
0.030
Why?
Time
1
2018
87
0.030
Why?
Telangiectasia, Hereditary Hemorrhagic
1
1998
14
0.030
Why?
Polymorphism, Single-Stranded Conformational
1
1997
25
0.030
Why?
Cell Cycle Checkpoints
1
2018
97
0.030
Why?
Genes, Tumor Suppressor
1
1998
85
0.030
Why?
Alveolitis, Extrinsic Allergic
1
1998
91
0.030
Why?
Gene Expression Profiling
1
2005
1773
0.030
Why?
Polymorphism, Restriction Fragment Length
1
1997
68
0.030
Why?
Likelihood Functions
1
1998
143
0.030
Why?
DNA, Complementary
1
1998
275
0.030
Why?
Gene Expression Regulation, Enzymologic
1
1998
270
0.030
Why?
Codon
1
1997
92
0.030
Why?
Neoplasm Staging
2
2012
1404
0.030
Why?
Introns
1
1998
253
0.030
Why?
Mice, Nude
1
1998
701
0.030
Why?
United States
2
2011
15447
0.030
Why?
Membrane Glycoproteins
1
1999
496
0.030
Why?
Immunoassay
2
1998
110
0.030
Why?
Enzyme Activation
1
1998
785
0.030
Why?
Incidence
3
2010
2826
0.030
Why?
Treatment Outcome
1
2011
11298
0.030
Why?
RNA, Neoplasm
1
1996
80
0.030
Why?
Glycopeptides
1
1996
44
0.030
Why?
Mesothelioma
1
1996
46
0.030
Why?
Image Processing, Computer-Assisted
1
2020
771
0.030
Why?
Sequence Analysis, DNA
1
1998
820
0.030
Why?
Proto-Oncogene Proteins
1
2018
622
0.030
Why?
Antigens, CD
2
1998
545
0.030
Why?
Receptors, Peptide
1
1994
19
0.030
Why?
Machine Learning
1
2020
567
0.030
Why?
Cell Cycle Proteins
1
2018
634
0.030
Why?
Databases, Factual
1
2020
1458
0.030
Why?
Myelin Sheath
1
1996
164
0.030
Why?
Rh-Hr Blood-Group System
1
1994
14
0.030
Why?
Erythrocyte Membrane
1
1994
52
0.030
Why?
Blotting, Southern
1
1993
76
0.030
Why?
Blotting, Northern
1
1993
200
0.030
Why?
Neoplasm Metastasis
1
1996
676
0.020
Why?
Prospective Studies
3
2012
7862
0.020
Why?
DNA, Neoplasm
1
1993
159
0.020
Why?
Cells, Cultured
2
2007
4167
0.020
Why?
Solid Phase Microextraction
1
2012
9
0.020
Why?
Endoscopy
1
2015
327
0.020
Why?
Dinoprostone
2
2004
181
0.020
Why?
Fluorescent Antibody Technique
1
1993
381
0.020
Why?
Breath Tests
1
2012
77
0.020
Why?
Cloning, Molecular
1
1993
532
0.020
Why?
Gas Chromatography-Mass Spectrometry
1
2012
134
0.020
Why?
Colorado
1
2002
4638
0.020
Why?
Enzyme Inhibitors
1
1996
837
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2018
1453
0.020
Why?
Liver Neoplasms
1
1998
755
0.020
Why?
Iceland
1
2011
11
0.020
Why?
Tumor Suppressor p53-Binding Protein 1
1
2011
13
0.020
Why?
Spain
1
2011
48
0.020
Why?
Netherlands
1
2011
86
0.020
Why?
Respiratory Tract Diseases
1
1992
180
0.020
Why?
Cattle
1
1993
988
0.020
Why?
Rats, Sprague-Dawley
1
1996
2523
0.020
Why?
Administration, Oral
1
2012
835
0.020
Why?
Meta-Analysis as Topic
1
2011
169
0.020
Why?
Severity of Illness Index
1
2018
2927
0.020
Why?
Carrier Proteins
1
1994
743
0.020
Why?
Receptor, IGF Type 1
1
2009
64
0.020
Why?
Prognosis
2
2012
4112
0.020
Why?
Flow Cytometry
1
1993
1185
0.020
Why?
Area Under Curve
1
2010
326
0.020
Why?
International Agencies
1
2009
32
0.020
Why?
Cystic Fibrosis
1
1998
1132
0.020
Why?
Erythrocytes
1
1994
701
0.020
Why?
Mass Spectrometry
1
2010
738
0.020
Why?
Chromatography, High Pressure Liquid
1
1989
590
0.020
Why?
Genome, Human
1
2009
425
0.020
Why?
Pilot Projects
1
2012
1829
0.020
Why?
Models, Statistical
1
2010
677
0.020
Why?
Genotype
1
2011
1866
0.010
Why?
Amino Acids
1
1989
505
0.010
Why?
Disease Models, Animal
1
1996
4483
0.010
Why?
Receptors, Vascular Endothelial Growth Factor
1
2005
108
0.010
Why?
Genomics
1
2009
820
0.010
Why?
Epoprostenol
1
2004
131
0.010
Why?
Bronchiolitis
1
2004
84
0.010
Why?
Autoantibodies
1
2010
1482
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
985
0.010
Why?
Fruit
1
2003
146
0.010
Why?
Vegetables
1
2003
161
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2004
759
0.010
Why?
Respiratory Function Tests
1
2004
559
0.010
Why?
Pituitary Neoplasms
1
2004
195
0.010
Why?
Genetic Predisposition to Disease
1
2011
2388
0.010
Why?
Adenoma
1
2004
218
0.010
Why?
Regression Analysis
1
2003
1013
0.010
Why?
Single-Blind Method
1
2001
290
0.010
Why?
Weight Gain
1
2004
542
0.010
Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2000
50
0.010
Why?
Carcinoma
1
2001
230
0.010
Why?
Bronchoscopes
1
1998
3
0.010
Why?
RNA
1
2005
929
0.010
Why?
Endoglin
1
1998
18
0.010
Why?
Random Allocation
1
1998
370
0.010
Why?
Genetic Linkage
1
1998
288
0.010
Why?
Reference Values
1
1998
807
0.010
Why?
Retrospective Studies
1
2015
16626
0.010
Why?
Comorbidity
1
2001
1678
0.010
Why?
Linear Models
1
1998
857
0.010
Why?
Tumor Suppressor Protein p53
1
2000
531
0.010
Why?
Longitudinal Studies
1
2003
2980
0.010
Why?
Analysis of Variance
1
1998
1313
0.010
Why?
Receptors, Cell Surface
1
1998
376
0.010
Why?
Diet
1
2003
1284
0.010
Why?
Alleles
1
1998
885
0.010
Why?
Risk Assessment
1
2004
3562
0.010
Why?
Chromatography, Affinity
1
1994
85
0.010
Why?
Infant, Premature
1
1998
604
0.010
Why?
Young Adult
1
2011
13878
0.010
Why?
CD47 Antigen
1
1994
43
0.010
Why?
Genes
1
1994
229
0.010
Why?
Electrophoresis, Polyacrylamide Gel
1
1994
333
0.010
Why?
Endothelium, Vascular
1
2000
951
0.010
Why?
Moths
1
1994
53
0.010
Why?
Cytoplasm
1
1994
267
0.010
Why?
Carcinoid Tumor
1
1992
22
0.010
Why?
Chromosome Mapping
1
1994
502
0.010
Why?
Transfection
1
1994
936
0.010
Why?
Lymphocytes
1
1994
395
0.010
Why?
Adolescent
1
2011
22326
0.010
Why?
Mice, Inbred BALB C
1
1994
1267
0.010
Why?
Dyspnea
1
1992
259
0.010
Why?
Binding Sites
1
1994
1317
0.010
Why?
Fibrosis
1
1992
545
0.000
Why?
Phenotype
1
1998
3184
0.000
Why?
Aging
1
1998
1931
0.000
Why?
Infant, Newborn
1
1998
6324
0.000
Why?
Infant
1
1998
9908
0.000
Why?
Child, Preschool
1
1998
11634
0.000
Why?
Child
1
1998
22562
0.000
Why?
Miller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)